Hillstream BioPharma (NASDAQ:HILS) | Finanzwire

Basculer en Français

8295	Companies
114831	Keywords
55272	Articles
62429	Press releases

Home
Companies
Hillstream BioPharma

BRIEF

published on 09/30/2024 at 13:05, 1 month 20 days ago

Tharimmune and Intract Pharma to Merge and Form Transformative Oral Biologics Company

Merger Biotechnology Tharimmune Intract Pharma Oral Biologics
PRESS RELEASE

published on 09/30/2024 at 13:00, 1 month 20 days ago

Tharimmune Signs Nonbinding Letter of Intent to Merge With Intract Pharma to Create Transformative Oral Biologic Therapeutics Company
Tharimmune, Inc. and Intract Pharma to merge, creating transformative oral biologics company. Merger expected to enhance pipeline growth, innovation, and patient outcomes in the biologics market

Merger Tharimmune Intract Pharma Oral Biologics Pipeline Growth
BRIEF

published on 09/16/2024 at 13:05, 2 months 4 days ago

Tharimmune Acquires Global License and Partners With Intract Pharma to Develop Oral Infliximab

Autoimmune Diseases Tharimmune Intract Pharma Infliximab Oral Delivery
PRESS RELEASE

published on 09/16/2024 at 13:00, 2 months 4 days ago

Tharimmune Acquires Global License and Partners With Intract Pharma to Develop an Oral Formulation of Infliximab
Tharimmune partners with Intract Pharma to license oral anti-TNF-α antibody for autoimmune diseases. The innovative delivery platform aims to enhance treatment effectiveness and patient compliance

Autoimmune Diseases Tharimmune Intract Pharma Oral Delivery Anti-TNF-α Antibody
PRESS RELEASE

published on 09/22/2023 at 14:30, 1 year 1 month ago

Hillstream BioPharma Progressing Towards Acquiring Clinical Stage Asset and Announces Corporate Name Change to Tharimmune, Inc.

Accesswire

Published on 11/21/2024 at 10:03, 34 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 37 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 37 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 2 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 12 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:04, 32 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 35 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 37 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 37 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 36 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 39 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 17 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 52 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 52 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE